Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03610971 |
| Title | Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | H. Lee Moffitt Cancer Center and Research Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | United States | Details | |
| Emory -Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| Memorial Sloan Kettering - Bergen | Montvale | New Jersey | 07645 | United States | Details | |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | United States | Details | |
| David H. Koch Center for Cancer Care at Memorial Sloan Kettering | New York | New York | 10021 | United States | Details | |
| Duke University Hospital | Durham | North Carolina | 27710 | United States | Details | |
| Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |